EL.En. S.p.A. (ELN) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of EL.En. S.p.A. stock €17.96, price €15.96, upside +12.6%, quality 74 out of 100. Rating: undervalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 3, 2026.
How to read this chart
60‑month range €7.17 – €17.48 · fair‑value band €13.64 – €23.31 · the €15.96 price screens below the €17.96 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 3, 2026.
Follow EL.En. S.p.A. in your weekly email
Every Wednesday you see whether EL.En. S.p.A. is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
EL.En. S.p.A. engages in the production, research and development, distribution, and sale of laser systems in Italy, Rest of Europe, and internationally. The company offers laser systems for the medical sector and the industrial sector.
Show moreShow less
It also develops, manufactures, and markets products, including solid-state laser, semiconductor laser, active fiber laser, dye lasers, and CO2 laser, as well as radio frequency, microwaves, frequency conversion systems, and high-intensity electromagnetic fields.
In addition, the company is involved in medical research and development activities, such as body shaping, gynecology and urology, dermatology sector, and hair removal; industrial research and development, including metal cutting, dies, marking, and textile and jeans.
EL.En. S.p.A. was founded in 1981 and is headquartered in Calenzano, Italy.
Stock analysis
EL.En. S.p.A. (ELN) currently trades at €15.96, while our model-based Fair Value estimate is €17.96, implying the stock looks roughly 11% undervalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of €13.66 per share, and 2 of the 26 models we run sit above the €15.96 price.
Bear case: the Dividend Discount group reads lowest at €2.37, and 24 of the 26 models stay below the price. Data coverage for this calculation is high.
Scenario range: €13.64 (bear) to €23.31 (bull), the price of €15.96 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 74/100 (solid quality), in the Healthcare sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
EL.En. S.p.A. reported revenue of €591M in FY2025 versus €571M in FY2021, a compound +0.8%/yr. Reported net income was €43.4M in FY2025, compounding −1.1%/yr from FY2021.
Key figures
Market cap €1.3B Small · P/E ratio 27.5 · P/S ratio 2.33 · EPS (TTM) €0.5800 · Dividend yield 1.6% · Net margin 8.4% · Return on equity 14.4% · Return on assets (EBIT) 10.5% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 55 out of 100 (low confidence).
What moves the price
The share trades about 9% below its 52-week high and 49% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −15% fair-value upside, at 13%, ELN screens cheaper than that median.
Fair Value models
Bear€13.64Fair Value €17.96Bull€23.31
Price €15.96 · Upside +12.6%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (€0.2821 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.72/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+12.5%
Earnings growth per share plus dividend.
Earnings per share, growth per year+10.9%
Dividend (yield on the price)1.6%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.10.9% vs 9.7%, steady
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.7% → 12%
Pace: the 5-year rate starts in 2020 (pandemic)
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+17.0%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+1.5%
Yearly sales growth analysts expect, extended to five years.
After inflation (euro area: IMF forecast 2.2% a year to 2030, 2.6% from 2016 to 2025) that is about +14.5% a year for the price and −0.7% for the forecasts.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 320 stocks
Beats the industry median on 11/14 measures
Overall it ranks above its industry peers.
Valuation
Quality Score74 · Top 25%
Fair Value upside+12.6% · Top 25%
Profitability
Return on equity (12 months)14.4% · Top 25%
Return on assets6.9% · Top 25%
Net margin (12 months)8.4% · Above median
Operating margin (12 months)14.3% · Above median
Growth and dividend
Revenue growth (quarter YoY)24.8% · Top 25%
Dividend yield (12 months)1.6% · Below median
Balance sheet
Debt / equity0.02× · Below median
Valuation Multiplesvs Medical Devices median · lower = cheaper
P/E (12 months)27.5× · Pricier than median
P/B3.46× · Priciest 25%
P/S (12 months)2.33× · Cheaper than median
Price / free cash flow (fiscal year)24.1× · Cheaper than median
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "EL.En. S.p.A. Fair Value". https://www.fairvalue-calculator.com/stock/ELN
Frequently asked questions
Is EL.En. S.p.A. (ELN) overvalued or undervalued?
As of Nov 3, 2026, our model estimates a fair value of €17.96 versus a price of €15.96, about +13% upside (undervalued).
What is the fair value of ELN?
Our model-based fair value for EL.En. S.p.A. is €17.96 (as of Nov 3, 2026), built from audited fundamentals. The current price: €15.96.
What is the quality score of ELN?
EL.En. S.p.A. has a Quality Score of 74/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for EL.En. S.p.A. (ELN)?
Our model-based price target is the fair value of €17.96 (as of Nov 3, 2026) from 26 valuation models. Cautious scenario €13.64, optimistic scenario €23.31. It is a calculation from audited fundamentals, not an analyst target.
What is the EL.En. S.p.A. stock forecast for 2026?
Our models put fair value at €17.96, about +13% upside versus a price of €15.96 (undervalued). Cautious scenario €13.64, optimistic scenario €23.31. The calculation is refreshed regularly with new filings.
What is the revenue of EL.En. S.p.A. (ELN)?
EL.En. S.p.A. reported trailing-twelve-month revenue of about €611M (latest available figure, as of Nov 3, 2026).
Does EL.En. S.p.A. pay a dividend?
EL.En. S.p.A. currently shows a dividend yield of 1.57% relative to its recent price (as of Nov 3, 2026).
How much is the dividend of EL.En. S.p.A. (ELN) and when is the ex-dividend date?
EL.En. S.p.A. pays a dividend of €0.25 per share a year, a dividend yield of 1.6%. The last ex-dividend date was May 25, 2026. A dividend has been paid every year since 2013. The payout ratio is 43.1% of earnings. Free cash flow covers the dividend 2.95 times. Our assessment: Well covered. A low payout and the dividend is fully funded by free cash flow, a comfortable, sustainable dividend.
What growth is priced into EL.En. S.p.A. (ELN)?
For today's price to be fair in a discounted-cash-flow model, EL.En. S.p.A. would have to grow free cash flow by +17.0 % per year for five years (discount rate 13.7 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +7.7 % per year. As of Nov 3, 2026.
What discount rate (WACC) does the fair value of ELN use?
Our models discount EL.En. S.p.A. at 13.7 %: a base by market capitalisation (small), damped by beta 1.07, country premium for Italy. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For EL.En. S.p.A. that is +17.0 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (13.7 %) and the same formula as our fair value.
How much growth has EL.En. S.p.A. (ELN) delivered so far?
Over the past 5 years revenue at EL.En. S.p.A. grew +7.7 % a year. The price currently implies free-cash-flow growth of +17.0 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of EL.En. S.p.A. (ELN) growing?
The median revenue growth in the sector is +6.2 % a year. That is the yardstick for the growth priced into EL.En. S.p.A. (+17.0 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of EL.En. S.p.A. (ELN)?
The free-cash-flow yield on the price is 4.63 %: that much free cash flow EL.En. S.p.A. produces per unit of market value. When it exceeds the discount rate of our models (13.7 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of EL.En. S.p.A. (ELN)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For EL.En. S.p.A. it is €17.96 per share (as of Nov 3, 2026), against a price of €15.96. It is the blended result of 26 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is EL.En. S.p.A. stock overvalued or undervalued in 2026?
As of Nov 3, 2026, ELN trades below its calculated fair value: price €15.96, fair value €17.96, a gap of about +13% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of ELN?
No. The price is what the market pays today (€15.96); the fair value is what the company's own numbers justify (€17.96). For EL.En. S.p.A. the two are €2.00 per share apart. That gap is exactly why we show both numbers side by side.
How much is EL.En. S.p.A. worth?
The market values EL.En. S.p.A. at about €1.3B (market capitalisation, as of Nov 3, 2026). Per share that is €15.96; our models calculate a fair value of €17.96 per share.
What do the bullish and bearish scenarios say about ELN?
Our models span a range for EL.En. S.p.A.: cautious scenario €13.64, base €17.96, optimistic €23.31 per share (as of Nov 3, 2026, price €15.96). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of ELN?
EL.En. S.p.A. trades at a price-to-earnings ratio of 27.5 (as of Nov 3, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of €17.96 is built from several models across several years. Median P/E at fiscal year-end, 5 fiscal years (2021 to 2025), reported earnings: 20.6. Other multiples: P/B 3.5, P/S 2.3, EV/EBITDA 13.3.
How solid is the balance sheet of EL.En. S.p.A. (ELN)?
Balance-sheet figures for EL.En. S.p.A. (as of Nov 3, 2026): return on equity 14.4%, debt of 0.02 per unit of equity. They feed the Quality Score of 74/100, which measures business quality independently of the share price.
How far is ELN from its 52-week high?
EL.En. S.p.A. trades at €15.96, about 9% below its 52-week high of €17.48 and 49% above the low of €10.69 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of €17.96 is for.
Which stocks are comparable to EL.En. S.p.A.?
From the same area (Healthcare) we also value Abbott Laboratories,, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is EL.En. S.p.A. stock attractive at the current price?
The data as of Nov 3, 2026: price €15.96, calculated fair value €17.96 (+13%), Quality Score 74/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of ELN calculated?
We run EL.En. S.p.A. through 26 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of €17.96 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0% above its aggregate fair value. EL.En. S.p.A. currently trades 11% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of EL.En. S.p.A. (ELN)?
The closing price on Nov 6, 2026 was €15.96. Our model-based fair value is €17.96, about +13% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with EL.En. S.p.A. right now?
The price sits in the lower half of our model range, the side with the larger margin of safety. The data supports the verdict: every model runs on fully documented inputs.
Where does the earnings growth of EL.En. S.p.A. (ELN) come from?
Earnings per share at EL.En. S.p.A. grew +7.6 % a year from 2014 to 2025. Broken into its drivers: revenue per share +11.8 %, EBIT margin +1.9 %, tax rate −1.1 %, residual (interest, one-offs) −4.6 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of EL.En. S.p.A.
How large is the market capitalisation of EL.En. S.p.A. (ELN)?
The market capitalisation of EL.En. S.p.A. is €1.3B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of EL.En. S.p.A. (ELN)?
The price-to-sales ratio of EL.En. S.p.A. is 2.33 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of EL.En. S.p.A. (ELN)?
Earnings per share at EL.En. S.p.A. are €0.5800 (price ÷ EPS = P/E 27.5). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of EL.En. S.p.A. (ELN)?
The dividend yield of EL.En. S.p.A. is 1.6% (payout 43.1%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of EL.En. S.p.A. (ELN)?
The net margin of EL.En. S.p.A. is 8.4% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of EL.En. S.p.A. (ELN)?
The return on equity (ROE) of EL.En. S.p.A. is 14.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of EL.En. S.p.A. (ELN)?
On an EBIT basis the return on assets of EL.En. S.p.A. is 10.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of EL.En. S.p.A. (ELN)?
The operating margin of EL.En. S.p.A. is 14.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at EL.En. S.p.A. (ELN)?
Revenue at EL.En. S.p.A. is growing +24.8% versus a year earlier (3y avg −4.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at EL.En. S.p.A. (ELN)?
Earnings per share at EL.En. S.p.A. are growing −6.3% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does EL.En. S.p.A. (ELN) hold?
EL.En. S.p.A. holds more cash than debt, €136M net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch EL.En. S.p.A. in the live analysis
One click puts EL.En. S.p.A. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Broad data
Nov 3, 2026